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T he World Health Organization (WHO) histologi-cal classification system for thymic epithelial neo-
plasm (TEN) was proposed in 1999 and updated in 
2004 [1] and has been widely adopted for independent 
prognostic factors [2 , 3].  The overall survival rates of 
patients with type A,  AB,  or B1 TEN are higher than 
those of patients with type B2 or B3 TEN [4].  
Moreover,  a meta-analysis clearly showed that thymo-
mas can be distinguished in different prognostic sub-
groups because carcinomas are neoplasms with a more 
aggressive malignant potential [5].
Preoperatively,  TENs are diagnosed by morphologic 
examinations such as computed tomography (CT) and 
magnetic resonance imaging (MRI).  However,  there 
are some overlapping features in the histological sub-
types of TEN according to the WHO classification [6].  
An earlier study of 33 TEN cases demonstrated that 
mediastinal fat invasion was an indicator for differenti-
ating 3 risk groups and had a prediction rate of approx.  
76% using discriminant analyses [7].
To evaluate TENs,  18-fluorine fluorodeoxyglucose 
(F-18 FDG) positron emission tomography/computed 
tomography (PET/CT) has been proposed as an 
advanced noninvasive imaging method.  The correla-
tion between FDG uptake and the WHO classification 
has been investigated [7-13],  and several of these stud-
ies examined the diagnostic capacity of single-time-
point (STP) PET/CT for the determination of carci-
noma in 28 to 46 TEN patients [9 , 11-13].  In those 
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analyses,  PET images were analyzed with qualitative or 
semiquantitative methods,  such as the calculation of the 
maximum standardized uptake value (SUVmax) or the 
tumor-to-mediastinum (T/M) ratio.  Several recent 
studies have shown the usefulness of dual-time-point 
(DTP) PET for evaluating the malignant nature [14-16].  
For the TEN patients,  only one study has reported the 
performance of DTP PET/CT using 60-min and 3-h 
scans after tracer injection with no evaluation of the 
diagnostic accuracy of the delayed-scan for carcinoma 
[11].
The aim of the present study was to retrospectively 
assess the DTP PET/CT findings of TEN cases using a 
simplified WHO classification scheme that employs 3 
risk groups: type A,  AB,  and B1 = low-risk thymoma 
(LR); B2 and B3 = high-risk thymoma (HR); and thy-
mic carcinoma (CA).  We also investigated the diagnos-
tic capacity of PET/CT for differentiating thymic carci-
noma from thymoma and compared it to the diagnostic 
capacity of chest CT.
Materials and Methods
Patients. The study was a retrospective analysis 
of data collected between August 2006 and September 
2014 at Okayama University Hospital.  A total of 56 
patients were included (32 men,  24 women; age [mean 
± SD] 60.63 ± 14.98; range 21-86 years).  The inclusion 
criteria were as follows.  Each patient had: a minimum 
patient age of 20 years; a definitive diagnosis of TEN; a 
chest CT at our institution and an F-18 FDG PET/CT at 
an adjacent imaging center before biopsy or surgery;  
no therapy before the PET/CT and CT examination.  
We classified the TENs using the WHO criteria.  Each 
TEN was also graded into one of the above-described 3 
risk groups by pathologists who were unaware of the 
PET results.  All tumors were staged according to the 
Masaoka clinical-pathologic staging system [17].
This study was approved by the ethical committee of 
our institution (approval no. 2244),  and the require-
ment for the patients’ informed consent was waived.
F-18 FDG PET/CT and image data analysis. For 
the F-18 FDG PET/CT,  the patient fasted for at least 5 
h,  after which blood glucose levels were determined to 
ensure a level of < 140 mg/dL.  The patient then received 
an intravenous injection of 3.7 MBq/kg of body weight 
(1.0 × 10−4 Ci/kg) of F-18 FDG.  With the patient in a 
relaxed supine position,  the PET/CT image acquisition 
started at 90 min (early phase) and at 2 h (delayed 
phase) after the FDG injection,  using an integrated 
PET/CT scanner (Biograph LS/Sensation 16,  Siemens,  
Munchen,  Germany).  First,  a total-body low-dose CT 
scan for the calculation of attenuation correction was 
performed.  It used a standardized protocol involving 
140 kV,  12 to 14 mAs,  a tube-rotation time of 0.5 sec 
per rotation,  a pitch of 0.8,  a section thickness of 
3 mm,  and a scan field from head up to the mid-thigh 
level.
Subsequently,  PET images consisting of 7-8 bed 
positions with 2.4 min per table position over the same 
region were obtained using a three-dimensional 
high-sensitivity mode with an axial field of view of 
70-cm in a 168 × 168 matrix.  A 46-mm overlap was 
used between the bed positions.  The PET images were 
reconstructed iteratively on a 168 × 168 matrix using an 
ordered-subset expectation maximization (OSEM) 
algorithm for 8 subsets and 2 iterations,  with a 5.0-mm 
post-reconstruction filter.  In-plane resolution of 4.2-
mm and axial resolution of 2.0-mm were obtained.  The 
PET images were reconstructed with an OSEM iterative 
reconstruction algorithm.
Two nuclear physicians unaware of the histological 
results interpreted all PET/CT findings by consensus.  
First,  the SUVmax was adopted for the semiquantita-
tive evaluation of FDG uptake.  It was calculated using 
the following formula: SUVmax = maximum tissue 
concentration (MBq/g)/injected radioactivity (Bq) per 
body weight (g).  The SUVmax calculation required 
manually setting the volume of interest (VOI).  The T/M 
ratio,  which is the ratio of the tumor SUVmax to the 
background mediastinum SUVmax,  was then deter-
mined for each patient.  The aortic arch was taken as the 
reference region for mediastinal activity.
For a semiquantitative analysis of FDG uptakes,  we 
used the T/M ratio in order to avoid the bias derived 
from the use of SUVmax,  which could be altered by 
several technical factors [18 , 19].  The T/M ratio mea-
surements were obtained for both the early scan (T/M 
ratio1) and the delayed scan (T/M ratio 2).  VOIs were 
drawn to encompass the TEN contours on PET/CT 
images.
Chest CT and image analysis. Because the study 
design was retrospective,  a variety of multidetector CT 
scanners had been used.  At our institution,  CT images 
were obtained with breath holding and the following 
parameters: 120 kVp,  300 mA of auto mA mode,  and 
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a section thickness interval of 5 mm depending on the 
protocol used.  In almost all of the patients (n = 53),  
intravenous nonionic contrast medium had been 
administered via an antecubital vein at a rate of 2.0-
3.0 ml/s with a 30- to 50-sec delay.  All image data were 
displayed as mediastinal window images (level,  30 HU;  
width,  350 HU).
The CT scans were reviewed by two radiologists,  
and differences in their findings were resolved by con-
sensus.  The CT scan findings were assessed in terms of 
the tumor size,  the contour of the tumor,  the presence 
of pleural effusion,  and other tumor features (i.e.,  
homogeneousness,  the presence of calcification,  medi-
astinal fat infiltration,  great vessel invasion,  and lymph 
node adenopathy).  The maximum diameter of each 
patient’s tumors was determined from the CT images.  
The tumor contours were subclassified as smooth or 
lobulated.  The homogeneousness was assessed as 
homogeneous or heterogeneous on plain CT for three of 
the 56 TENs.  On enhanced CT,  the enhancement pat-
terns were recorded as homogeneous or heterogeneous 
for the other 53 TENs.
Statistical analysis. Paired t-test statistics were 
used for the analysis between the T/M ratio1 and T/M 
ratio2 for each tumor type.  To analyze the relationship 
between the tumor types and the T/M ratio,  we 
employed the t-test for unpaired observations and a 
one-way analysis of variance (ANOVA) test followed by 
Bonferroni’s multiple comparison test for more than 2 
variables.  We used receiver operating characteristic 
(ROC) curve analyses to determine the T/M ratio values 
for carcinoma in both the early and delayed scans that 
maximized the sensitivity and specificity.
For the CT features of the TENs,  we used a multi-
variate logistic regression (MLR) analysis to estimate 
the probability (p-value),  odds ratio (OR),  and 95% 
confidence interval (CI) of the carcinomas.  The analysis 
was first done in a univariate fashion,  and then all of the 
covariates with a p-value < 0.10 in the univariate analysis 
were included in the multivariate analysis that yielded a 
model.  We performed the ROC curve analysis to eval-
uate the predictive performance of the CT model by 
assessing its discrimination.  Discrimination was 
assessed by the area under the curve (AUC).
All statistical analyses were performed using the 
SPSS Statistics 22 software program (IBM,  Armonk,  
NY,  USA).  A p-value < 0.05 was considered significant 
for all analyses.
Results
Patients and tumor characteristics. A total of 56 
patients met the criteria for the analysis of STP PET/CT 
scans.  Forty-eight patients underwent surgical resec-
tion and the remaining eight patients underwent a core 
biopsy.  Table 1 shows the characteristics of the patients.  
Histopathologically,  27 cases were classified as LR (9 
type A,  7 type AB,  and 11 type B1),  14 were classified 
as HR (9 type B2,  5 type B3),  and 15 were classified as 
CA.  The tumor long-axis diameter ranged from 15 to 
107 mm with a mean of 53.04 mm in the LR cases,  
from 19 to 84 mm with a mean of 46.71 mm in the HR 
cases,  and from 29 to 118 mm with a mean of 73.47 mm 
in the CA cases.  A significant difference in diameter 
was identified between the HR and CA cases (p = 0.010) 
and between the LR and CA cases (p= 0.022).  There was 
no significant difference in diameter between the LR 
and HR cases (p = 0.449).
A total of 35 patients met the criteria for the analysis 
of DTP PET/CT scans.  Histopathologically,  17 cases 
were classified as LR (5 type A,  5 type AB,  and 7 type 
B1),  nine cases were classified as HR (7 type B2,  2 type 
B3),  and nine cases were classified as CA.  The tumor 
long-axis diameter ranged from 15 to 85 mm with a 
mean of 51.71 mm in the LR cases,  from 19 to 84 mm 
with a mean of 43.44 mm in the HR cases,  and from 32 
to 100 mm with a mean of 71.50 mm in the CA cases.  
A significant difference in diameter was identified 
between the HR and CA cases (p = 0.024).  There were 
no significant differences in diameter between the LR 
and HR cases (p = 0.466) or between the LR and CA 
cases (p = 0.071).
The tumor-to-mediastinum ratio on F-18 FDG 
PET/CT. In the STP scanning of all 56 patients,  the 
mean T/M ratio 1 ± SD was 2.12 ± 0.762 (range,  0.77-
4.34) for all of the TENs.  In a simplified WHO classifi-
cation scheme,  the mean T/M ratio 1 ± SD was 
2.18 ± 0.784 (range,  0.77-4.34) for the LR TENs,  
2.00 ± 0.730 (range,  0.88-3.25) for the HR TENs,  and 
5.60 ± 5.68 (range,  1.31-24.6) for the CA TENs.
Table 2 shows the T/M ratio 1 and T/M ratio 2 values 
on the DTP scans for 35 patients.  There were no signif-
icant differences between the T/M ratio 1 and T/M 
ratio 2 values for all 3 groups,  i.e.,  LR,  HR,  and CA.  
For all of these TENs,  the mean T/M ratio 1 ± SD was 
2.14 ± 0.818 (range,  0.77-4.34) and the T/M ratio 2 ± SD 
was 2.24 ± 0.955 (range,  0.86-4.76).  In the simplified 
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WHO classification scheme,  the mean T/M ratio ± SD 
was 2.20 ± 0.857 (range,  0.77-4.34) for T/M ratio 1 and 
2.29 ± 0.984 (range,  0.97-4.76) for T/M ratio 2 in the LR 
TENs,  2.02 ± 0.775 (range,  0.88-3.25) for T/M ratio 1 
and 2.15 ± 0.949 (range,  0.86-3.56) for T/M ratio 2 in 
the HR TENs,  and 3.57 ± 1.234 (range,  1.31-5.24) for 
T/M ratio 1 and 3.84 ± 1.558 (range,  1.45-6.39) for T/M 
ratio 2 in the carcinomas.  Nine of the 17 LR TENs,  5 of 
the nine HR TENs,  and 6 of the 9 carcinomas showed a 
T/M ratio 2 that was higher than the T/M ratio 1.
The relationship between the tumor types and tracer 
uptake. In the STP scans of the 56 tumors,  the T/M 
ratio 1 was significantly higher in the carcinomas than in 
all of the TENs (p = 0.000276).  The T/M ratio 1 was sig-
nificantly higher in the carcinomas than in both the LR 
TENs (p = 0.002) and the HR TENs (p = 0.006).  No sig-
nificant difference was identified in the T/M ratio 1 
between the LR and HR TENs (p = 1.000)
As illustrated in Fig. 1 and 2,  in the DTP scans of 35 
of the tumors,  the T/M ratio was significantly higher in 
the carcinomas than in all of the TENs on both the early 
and delayed scans (p = 0.000388 for T/M ratio 1;  
p = 0.001 for T/M ratio 2).  The T/M ratio 1 was signifi-
cantly higher in the carcinomas than in both the LR 
TENs (p = 0.004) and HR TENs (p = 0.005).  No signifi-
cant difference was identified in the T/M ratio1 between 
the LR and HR TENs (p = 1.000).  The T/M ratio 2 was 
significantly higher in the carcinomas than both in the 
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Table 2　 Tumor/mediastinum ratios on dual-time-point (DTP) scans of 35 patients
WHO classiﬁcation No. of tumors T/M ratio 1 (early) T/M ratio 2 (delayed)
Low-risk group 17 2.20±0.857 2.29±0.984
　　　　Type A  5 2.44±1.096 2.55±1.307
　　　　Type AB  5 1.94±1.053 2.03±1.156
　　　　Type B1  7 2.20±0.563 2.29±0.664
High-risk group  9 2.02±0.775 2.15±0.949
　　　　Type B2  7 2.19±0.742 2.37±0.924
　　　　Type B3  2 1.44±0.792 1.37±0.721
Thymic carcinoma  9 3.57±1.234 3.84±1.558
T/M ratio＝ the ratio of the peak SUV of the tumor to the peak.
SUV of the aortic arch.
The data are mean ± SD.
Table 1　 Characteristics of the patients and tumors
Low-risk High-risk Carcinoma
No. of patients (%) 27 (48%) 14 (25%) 15 (27%)
Sex
　　　　　Male 16 6 10
　　　　　Female 11 8  5
Age (mean yr,  range) 59.00 (25-86) 64.93 (43-79) 59.53 (21-84)
Size (mm,  range) 53.04 (15-107)† 46.71 (19-84)＊ 73.47 (29-118)
WHO classiﬁcation
　　　　　A/AB/ B1 9/7/11
　　　　　B2/B3 10/4
　　　　　Carcinoma 15
Masaokaʼs classiﬁcation
　　　　　Ⅰ  9 3  0
　　　　　Ⅱ 12 7  1
　　　　　Ⅲ  5 4  7
　　　　　Ⅳa  0 0  3
　　　　　Ⅳb  1 0  4
＊p＝0.010 compared with thymic carcinoma.
†p＝0.022 compared with thymic carcinoma.
LR TENs (p = 0.008) and HR TENs (p = 0.011).  No sig-
nificant difference was identified in the T/M ratio 2 
between the LR and HR TENs (p = 1.000).
ROC curves and cut-off values for the T/M ratio.
In the STP PET/CT for all 56 TENs,  the ROC curve for 
T/M ratio 1 for predicting carcinoma revealed that the 
appropriate cut-off value for obtaining the highest accu-
racy was 2.39,  with a sensitivity of 86.7%,  specificity of 
73.2%,  and accuracy of 75.0%.  The AUC of the STP 
scans was 0.855 (95% CI; 0.713-0.998,  p = 0.000053).
In the DTP PET/CT for the 35 TENs,  the ROC 
curve for predicting carcinoma indicated that the 
appropriate cut-off value for the T/M ratio was 2.39 for 
T/M ratio 1,  with a sensitivity of 88.9%,  specificity of 
73.1%,  and accuracy of 74.3%,  and 2.96 for T/M ratio 2,  
yielding a sensitivity of 88.9%,  specificity of 80.8%,  and 
accuracy of 82.9%.  The AUC of the DTP scans was 
0.838 (95% CI; 0.658-1.000,  p = 0.03) for the early scans 
and 0.825 (95% CI; 0.650-0.999,  p = 0.004) for the 
delayed scans (Table 3).
CT features associated with thymic carcinoma.
The univariate analyses revealed that the tumors of the 
patients with carcinoma were significantly more likely to 
be larger (p = 0.009),  to include pleural effusion 
(p = 0.022),  to be homogeneous (p = 0.026),  and to be 
infiltrative to mediastinal fat (p = 0.001) (Table 4).  No 
significant differences were detected between the carci-
nomas and thymomas with respect to tumor contours,  
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Table 3　 Diagnostic performance of each parameter for the prediction of thymic carcinoma
No. of Patients Threshold Value Sensitivity (%) Speciﬁcity (%) Accuracy (%) AUC
Single-time-point scan
　　T/M ratio 1 (early) 56 2.39 86.7 73.2 75.0 0.855
Dual-time-point scan
　　T/M ratio 1 (early) 35 2.39 88.9 73.1 74.3 0.838
　　T/M ratio 2 (delayed) 35 2.96 88.9 80.8 82.9 0.825
CT model
　　Mediastinal fat inﬁltration 56 - - - - 0.853
T/M ratio,  the ratio of the peak standardized uptake value of the tumor to the peak standardized uptake value of aortic arch; CT,  com-
puted tomography; AUC,  the area under the curve.
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Fig. 1　 The correlation between the tumor-to-mediastinum ratio 
on the 90-min early scans (the T/M ratio 1) and the simpliﬁed WHO 
classiﬁcation scheme.  The T/M ratio 1 was signiﬁcantly higher in 
the thymic carcinomas than in all TENs (p＝0.000388) and both the 
low-risk TENs (p＝0.004) and high-risk TENs (p＝0.005). No sig-
niﬁcant diﬀerence was identiﬁed between the low-risk and high-risk 
TENs (p＝1.000).
Low-risk High-risk Carcinoma
T/
M
 r
at
io
2
6.00
4.00
2.00
.00
†p=0.008
‡p=0.011
p=0.001
† ‡
†
‡
Fig. 2　 The correlation between the tumor-to-mediastinum ratio 
on the 120-min delayed scans (the T/M ratio 2) and the simpliﬁed 
WHO classiﬁcation scheme.  The T/M ratio 2 was signiﬁcantly 
higher in the thymic carcinomas than in all TENs (p＝0.001) and 
both the low-risk (p＝0.008) and high-risk TENs (p＝0.011).  No 
signiﬁcant diﬀerence was identiﬁed between the low-risk and high-
risk TENs (p＝1.000).
the presence of calcification,  great vessel invasion,  or 
lymph node adenopathy.  We entered the variables of 
tumor size,  presence of pleural effusion,  homoge-
neousness,  and fat infiltration into the MLR analysis.
In the MLR analysis,  mediastinal fat infiltration 
(p = 0.018) was the predictor of carcinoma (Table 5).  
The ROC curve obtained for the CT model yielded an 
AUC of 0.853 (95% CI; 0.734-0.971,  p = 0.000059) 
(Fig. 3).
Discussion
The present study explored the correlation between 
the T/M ratio and the low-risk,  high-risk and carci-
noma groups of TEN cases on DTP PET/CT and the 
diagnostic capacity of PET/CT scans with ROC analy-
ses.  With either early or delayed scans for discriminat-
ing carcinoma from thymoma,  our ROC analyses 
showed acceptable diagnostic accuracy.  In addition,  
the MLR analysis demonstrated that mediastinal fat 
infiltration was a predictor that had moderate accuracy.  
These results show that the measurement of T/M ratio 
and the observation of CT features are important pre-
dictors of carcinoma and that,  with the use of an ROC 
analysis,  there is no distinction between the capabilities 
for diagnosis of carcinoma of one modality from that of 
the other.
Several clinical PET studies demonstrated the use-
fulness of STP PET for evaluations of the malignant 
nature of TEN and the correlation between FDG uptake 
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Table 5　 Multivariate logistic regression analysis for thymic carcinoma,  56 subjects
Variables Regression coeﬃcient P-value OR 95% CI
Mediastinal fat invasion 2.239 0.018 9.381 1.457-60.394
Pleural eﬀusion 1.581 0.229 4.858 0.369-63.959
Homogeneousness 1.123 0.263 3.074 0.431-21.933
Size 0.002 0.934 1.002 0.965-1.039
CT model (N=56)
T/M ratio1 (N=56)
TP
F
FPF
1.0
0.8
0.6
0.4
0.2
0.0
0.0 0.2 0.4 0.6 0.8 1.0
Fig. 3　 ROC curve for the thymic carcinomas.  The AUC value 
derived from the tumor-to-mediastinum ratio on the 90-min early 
scan (T/M ratio1) was 0.855 (95% CI 0.713-0.998,  p＝0.000053). 
The AUC derived from the multivariate logistic CT model was 
0.853 (95% CI 0.734-0.971,  p＝0.000059).
Table 4　 Signiﬁcant predictors of thymic carcinoma for all 56 patients
Variables Thymic carcinoma Thymoma P-value OR 95% CI
Tumor size (mm) 73.47 50.88 0.009 1.036 1.009-1.063
Pleural eﬀusion 0.022 14.545 1.472-143.729
　　　　　Positive  4  1
　　　　　Negative 11 40
Homogeneousness 0.026 6.19 1.238-30.961
　　　　　Homogeneous  2 20
　　　　　Heterogeneous 13 21
Mediastinal fat invasion 0.001 17.727 3.435-91.496
　　　　　Positive 13 11
　　　　　Negative  2 30
and the WHO classification [7-13].  Previous investiga-
tions showed that STP PET has an accuracy of 
79-88.5% for the detection of carcinomas [9 , 11-13].  
Inoue et al.  first mentioned delayed scanning for thymic 
tumors,  and they observed that 3-h delayed SUVmax 
values were higher than the early SUVmax values in all 
but 2 of 23 thymomas and three carcinomas [11].  
However,  they could find no advantages of 3-h delayed 
scanning for differentiating tumors.
In the present study,  the AUC values were in the 
same range with moderate accuracy (0.838 for T/M 
ratio1; 0.825 for T/M ratio 2).  Using the cut-off values,  
the present study yields an accuracy of 82.9% for the 
delayed scanning,  which is higher than the accuracy of 
74.3% for the early scanning in 26 thymomas and nine 
thymic carcinomas.  We hypothesize that the 2-h 
delayed scans may have the potential to slightly improve 
the diagnostic capacity of PET/CT for the diagnosis of 
carcinoma compared with that for the 90-min early 
scans.  The reason for the difference between the previ-
ous [11] and present studies may be a difference in 
study design,  such as the evaluation method (SUVmax 
or T/M ratio),  or the scan time-points for the DTP 
scans.  The clinical significance of DTP scanning thus 
remains a controversial issue,  and a prospective study 
with a larger number of patients is still needed to deter-
mine the diagnostic capacity of DTP scans in patients 
with TENs.
An earlier report mentioned that CT findings of 
irregular contour,  necrotic or cystic component,  het-
erogeneous enhancement,  lymphadenopathy,  and great 
vessel invasion were more commonly seen in carcino-
mas than low- or high-risk thymomas [20].  The present 
study’s MLR analysis and ROC analysis demonstrated 
that fat infiltration is a predictor of thymic carcinoma 
with moderate accuracy.  These discrepancies between 
studies may be due to (1) the relatively small number of 
patients and/or (2) the differing proportions of the 
WHO classification and/or clinical-pathologic stage.
In contrast,  Jeong et al.  found that three features,  
i.e.,  lobulated contour,  mediastinal fat invasion,  and 
great vessel invasion were all more often seen in carci-
nomas than low-risk thymomas [6],  and Sung et al.  
demonstrated by a discriminant analysis that mediasti-
nal fat invasion on enhanced CT was an indicator for 
differentiating 3 risk groups in 33 TENs,  with a predic-
tion rate of approx.  76% [7].  These results suggest that 
the finding of mediastinal fat infiltration has the poten-
tial to improve the diagnostic accuracy for carcinoma.
However,  at this time the CT findings are not suffi-
cient to change the standard criteria for open biopsy 
based on CT morphology.  The number of patients 
included in our study was too small to draw conclu-
sions,  but our data suggest that the CT finding of medi-
astinal fat invasion may have the potential to serve as a 
preoperative predictor of carcinoma with moderate 
diagnostic capacity.
Our study is limited by the relatively small number 
of patients included and the retrospective design.  
Further prospective investigations using a larger patient 
population comparing PET/CT and chest CT would be 
useful for evaluating the role of a DTP PET/CT scan 
and a chest CT for predicting carcinoma.  Despite its 
limitations,  this study was the first to evaluate the diag-
nostic capacity of DTP scans for TEN using ROC anal-
yses.  Moreover,  our study included a direct compari-
son between PET/CT and chest CT with regard to 
diagnostic efficacy for the discrimination of carcinoma 
from thymoma.
In conclusion,  the findings of the present study pro-
vide further evidence that PET/CT is an important 
noninvasive method for the evaluation of TEN using the 
T/M ratio.  Two-hour delayed scanning could have the 
potential to improve the diagnostic capacity for the 
diagnosis of carcinoma.  Measurements of the T/M ratio 
and the detection of mediastinal fat infiltration are 
important predictors of carcinoma,  and they could be 
predictive of carcinoma with moderate diagnostic accu-
racy.  Moreover,  each of these imaging parameters 
could be useful tools to avoid making the wrong diag-
nosis and to improve the reliability of those 2 modali-
ties.  We also observed no distinction between the capa-
bilities of one modality from that of the other for the 
diagnosis of carcinoma.
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